Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.

N Madelon; N Heikkilä; Royo I Sabater; P Fontannaz; G Breville; K Lauper; R Goldstein; A Grifoni; A Sette; CA Siegrist; A Finckh; PH Lalive; CS Eberhardt

doi:10.1001/jamaneurol.2022.0245

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.

N Madelon, N Heikkilä, Royo I Sabater, P Fontannaz, G Breville, K Lauper, R Goldstein, A Grifoni, A Sette, CA Siegrist, A Finckh, PH Lalive, CS Eberhardt

Division of Musculoskeletal & Dermatological Sciences

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	JAMA Neurology
DOIs	https://doi.org/10.1001/jamaneurol.2022.0245
Publication status	Published - Apr 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaneurol.2022.0245

Cite this

Madelon, N., Heikkilä, N., Sabater, R. I., Fontannaz, P., Breville, G., Lauper, K., Goldstein, R., Grifoni, A., Sette, A., Siegrist, CA., Finckh, A., Lalive, PH., & Eberhardt, CS. (2022). Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2022.0245

@article{1b17646c51d54037ad59881d5bbf983a,

title = "Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.",

author = "N Madelon and N Heikkil{\"a} and Sabater, {Royo I} and P Fontannaz and G Breville and K Lauper and R Goldstein and A Grifoni and A Sette and CA Siegrist and A Finckh and PH Lalive and CS Eberhardt",

year = "2022",

month = apr,

doi = "10.1001/jamaneurol.2022.0245",

language = "Undefined",

journal = "JAMA Neurology",

issn = "2168-6157",

publisher = "American Medical Association",

}

Madelon, N, Heikkilä, N, Sabater, RI, Fontannaz, P, Breville, G, Lauper, K, Goldstein, R, Grifoni, A, Sette, A, Siegrist, CA, Finckh, A, Lalive, PH & Eberhardt, CS 2022, 'Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.', JAMA Neurology. https://doi.org/10.1001/jamaneurol.2022.0245

TY - JOUR

T1 - Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.

AU - Madelon, N

AU - Heikkilä, N

AU - Sabater, Royo I

AU - Fontannaz, P

AU - Breville, G

AU - Lauper, K

AU - Goldstein, R

AU - Grifoni, A

AU - Sette, A

AU - Siegrist, CA

AU - Finckh, A

AU - Lalive, PH

AU - Eberhardt, CS

PY - 2022/4

Y1 - 2022/4

UR - http://europepmc.org/abstract/med/35212717

U2 - 10.1001/jamaneurol.2022.0245

DO - 10.1001/jamaneurol.2022.0245

M3 - Article

C2 - 35212717

SN - 2168-6157

JO - JAMA Neurology

JF - JAMA Neurology

ER -

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.

UN SDGs

Access to Document

Other files and links

Cite this